Header Logo

Connection

KENNETH MCCLAIN to Antibodies, Neoplasm

Back to Details
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Antibodies, Neoplasm.
KENNETH MCCLAIN
Connection Strength
0.055
Antibodies, Neoplasm
  1. Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005 Mar; 44(3):251-4.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.